Market Overview

Benzinga's Top Downgrades

Related ABT
Big Pharma Is Fighting Legalized Marijuana Any Way It Can
6 Big Pharma Companies Left To Report September Quarterly Figures
GE Blinks (Seeking Alpha)
Related LLTC
Earnings Scheduled For October 18, 2016
First Two Weeks Of October EPS Estimates All In One Place
Best And Worst Performing Stocks 2016 YTD (Seeking Alpha)

Analysts at Raymond James downgraded Abbott Laboratories (NYSE: ABT) from “outperform” to “market perform.” Abbott's shares closed at $69.04 yesterday. Abbott's trailing-twelve-month ROA is 8.67%.

Analysts at Nomura downgraded Linear Technology (NASDAQ: LLTC) from “buy” to “neutral.” Linear Technology's shares closed at $32.22 yesterday. Linear Technology's PEG ratio is 4.54.

Analysts at Stephens downgraded Halliburton Company (NYSE: HAL) from “overweight” to “equal weight.” Halliburton's shares closed at $35.32 yesterday. Halliburton's trailing-twelve-month profit margin is 10.66%.

Goldman Sachs downgraded St. Jude Medical (NYSE: STJ) from “buy” to “neutral.” St. Jude Medical's shares closed at $40.85 yesterday. St. Jude Medical's trailing-twelve-month ROE is 17.25%.

Latest Ratings for ABT

Sep 2016JefferiesMaintainsBuy
Aug 2016JefferiesMaintainsBuy
Jul 2016JefferiesMaintainsBuy

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (ABT + HAL)

View Comments and Join the Discussion!